Howard Capital Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.3M Buy
58,470
+591
+1% +$284K 1.79% 22
2026
Q1
$28.4M Buy
57,879
+1,304
+2% +$708K 1.89% 23
2025
Q4
$32.8M Sell
56,575
-916
-2% -$518K 2.07% 19
2025
Q3
$27.9M Buy
57,491
+475
+0.8% +$221K 1.77% 21
2025
Q2
$23.1M Buy
57,016
+1,990
+4% +$832K 1.61% 25
2025
Q1
$27.4M Sell
55,026
-206
-0.4% -$112K 2.13% 21
2024
Q4
$28.7M Buy
55,232
+657
+1% +$361K 1.97% 21
2024
Q3
$33.8M Buy
54,575
+286
+0.5% +$169K 2.37% 15
2024
Q2
$30M Buy
54,289
+632
+1% +$362K 2.21% 16
2024
Q1
$31.2M Buy
53,657
+670
+1% +$376K 2.4% 15
2023
Q4
$28.1M Buy
52,987
+584
+1% +$283K 2.44% 16
2023
Q3
$26.5M Buy
52,403
+839
+2% +$447K 2.56% 15
2023
Q2
$26.9M Sell
51,564
-626
-1% -$338K 2.51% 15
2023
Q1
$30.1M Sell
52,190
-200
-0.4% -$113K 3.18% 10
2022
Q4
$28.9M Sell
52,390
-519
-1% -$275K 3.46% 5
2022
Q3
$26.8M Sell
52,909
-222
-0.4% -$124K 3.39% 8
2022
Q2
$28.9M Sell
53,131
-786
-1% -$433K 3.39% 8
2022
Q1
$31.8M Sell
53,917
-489
-0.9% -$281K 2.9% 10
2021
Q4
$36.3M Sell
54,406
-575
-1% -$359K 3% 11
2021
Q3
$31.4M Buy
54,981
+179
+0.3% +$98.2K 2.91% 12
2021
Q2
$27.6M Buy
54,802
+1,015
+2% +$479K 2.6% 13
2021
Q1
$24.5M Buy
+53,787
New +$25.7M 2.57% 15

Other funds holding TMO

Howard Capital Management Group's TMO Position: Q2 2026 in Review

Howard Capital Management Group increased its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, buying an estimated $284K and bringing the position to 58,470 shares worth $29.3M. The position accounts for 1.79% of the portfolio, ranked #22.

Howard Capital Management Group first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $36.3M in Q4 2021. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Howard Capital Management Group held 58,470 shares of Thermo Fisher Scientific worth $29.3M as of Q2 2026.
  • Howard Capital Management Group bought 591 Thermo Fisher Scientific shares in Q2 2026, an estimated $284K.
  • Thermo Fisher Scientific made up 1.79% of Howard Capital Management Group's portfolio in Q2 2026, its #22 holding.
  • Howard Capital Management Group first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • Howard Capital Management Group's Thermo Fisher Scientific position peaked at $36.3M in Q4 2021.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.